Published in J Natl Cancer Inst on September 20, 2000
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst (2010) 1.89
Multidrug-resistant MCF-7 cells: an identity crisis? J Natl Cancer Inst (2002) 1.04
Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms. Int J Cancer (2011) 0.86
Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. J Natl Cancer Inst (2000) 2.33
Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. J Natl Cancer Inst (1998) 2.31
An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43
Features of apoptotic cells measured by flow cytometry. Cytometry (1992) 6.45
Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med (1991) 5.06
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol (1999) 4.98
The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage (2008) 4.39
Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology (1998) 3.95
Animal models for implant biomaterial research in bone: a review. Eur Cell Mater (2007) 3.48
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol (1993) 2.77
Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res (1999) 2.70
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer (2001) 2.67
Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet (2001) 2.63
Genetic variation of recent Alu insertions in human populations. J Mol Evol (1996) 2.56
Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ (2001) 2.40
Translation and mRNA decay. Mol Gen Genet (1978) 2.40
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer (2003) 2.33
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res (2001) 2.25
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood (2001) 2.25
Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet (2000) 2.24
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci (2000) 2.21
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med (1997) 2.07
Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope (2001) 2.06
More is not always better: a case for low-dose leucovorin. J Clin Oncol (1993) 2.03
Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01
Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol (2003) 1.94
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci (2001) 1.89
Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry (1990) 1.83
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta (2001) 1.82
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res (2001) 1.81
Duration and frequency of every day activities in total hip patients. J Biomech (2001) 1.80
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79
Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res (2000) 1.74
Two year longitudinal change and test-retest-precision of knee cartilage morphology in a pilot study for the osteoarthritis initiative. Osteoarthritis Cartilage (2007) 1.71
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol (1994) 1.70
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68
Tandem chromosomal duplications: role of REP sequences in the recombination event at the join-point. EMBO J (1990) 1.66
Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend (2006) 1.65
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg (2000) 1.65
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res (1999) 1.62
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Br J Cancer (2000) 1.60
NAD+ binding to the Escherichia coli K(+)-uptake protein TrkA and sequence similarity between TrkA and domains of a family of dehydrogenases suggest a role for NAD+ in bacterial transport. Mol Microbiol (1993) 1.56
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res (1999) 1.54
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia (2007) 1.52
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Lett (1999) 1.52
Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol (1998) 1.48
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst (1999) 1.46
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A (1994) 1.44
Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res (1986) 1.44
Radiological analysis of normal axial alignment of femur and tibia in view of total knee arthroplasty. J Arthroplasty (1993) 1.43
[Clinical relevance of signal-intense foci in cerebral magnetic resonance tomography in neurofibromatosis]. Fortschr Neurol Psychiatr (1991) 1.40
Cost of beta-adrenergic receptor blocking agents for ocular hypertension. Arch Ophthalmol (1992) 1.39
Animal models for fracture treatment in osteoporosis. Osteoporos Int (2005) 1.39
[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women]. Arch Gynakol (1972) 1.38
Acute mesenteric ischemia caused by spontaneous isolated dissection of the superior mesenteric artery: treatment by percutaneous stent placement. Eur Radiol (2000) 1.38
All three subunits are required for the reconstitution of an active proton channel (F0) of Escherichia coli ATP synthase (F1F0). EMBO J (1985) 1.36
Large scale purification, nucleotide binding properties, and ATPase activity of the MalK subunit of Salmonella typhimurium maltose transport complex. J Biol Chem (1992) 1.35
Estimation of mechanical properties of cortical bone by computed tomography. J Orthop Res (1991) 1.34
IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol (2001) 1.33
Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J Immunol (2000) 1.32
Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol (1995) 1.32
Bacterial adenosine 5'-triphosphate synthase (F1F0): purification and reconstitution of F0 complexes and biochemical and functional characterization of their subunits. Microbiol Rev (1987) 1.32
Apoptotic cell death in retinal degenerations. Prog Retin Eye Res (1998) 1.31
A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol (1999) 1.27
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer (2008) 1.27
Early temporary porosis of bone induced by internal fixation implants. A reaction to necrosis, not to stress protection? Clin Orthop Relat Res (1988) 1.27
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. Helicobacter (1998) 1.27
Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem (1998) 1.27
Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis (2003) 1.26
Immunological skin testing and interpretation: a plea for uniformity. Cancer (1979) 1.26
Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr Neurosci (2002) 1.24
Functional consequences of mutations in the conserved 'signature sequence' of the ATP-binding-cassette protein MalK. Eur J Biochem (1999) 1.23
Internal forces and moments in the femur during walking. J Biomech (1997) 1.22
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci U S A (1987) 1.22
Less invasive stabilization of complex tibial plateau fractures: a biomechanical evaluation of a unilateral locked screw plate and double plating. J Orthop Trauma (2004) 1.22
ATP modulates subunit-subunit interactions in an ATP-binding cassette transporter (MalFGK2) determined by site-directed chemical cross-linking. J Biol Chem (2000) 1.22
The ATP-binding cassette (ABC) transporter for maltose/maltodextrins of Salmonella typhimurium. Characterization of the ATPase activity associated with the purified MalK subunit. J Biol Chem (1993) 1.21
c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J Neurosci (2000) 1.20
Influence of muscle forces on femoral strain distribution. J Biomech (1998) 1.19
P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer (1991) 1.19
Principles of fixation of osteoporotic fractures. J Bone Joint Surg Br (2006) 1.17
Use of serum tumor markers in cancer diagnosis and management. Semin Oncol (1987) 1.17
Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett (2007) 1.17
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Ann Oncol (2004) 1.17
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J Cell Biochem (1997) 1.16
Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ (2002) 1.16
Biomechanics of the craniocervical region: the alar and transverse ligaments. J Orthop Res (1988) 1.15
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J Biol Chem (1989) 1.15
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood (1994) 1.14
Obesity and immunocompetence. Eur J Clin Nutr (2002) 1.13
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns. J Natl Cancer Inst (1997) 1.13